Chemoradiation: Clinical Trials

5 trials for Chemoradiation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 12Unknown 2
Phase 31Unknown 1

Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
Tislelizumab, Paclitaxel, Carboplatin - Esophageal Squamous Cell Carcinoma, Tislelizumab
Phase 1 / Phase 2UnknownJiangsu Cancer Institute & Hospital302022-05-012022-05-27
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
neoadjuvant chemoradiation - Esophageal Squamous Cell Carcinoma, Chemoradiation
Phase 2 / Phase 3UnknownNational Taiwan University Hospital2482017-03-012022-06-07
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
Hypo-fractionated radiotherapy, S1 - Gastric Cancer, Chemoradiation
Phase 1 / Phase 2UnknownChinese Academy of Medical Sciences182016-05-012018-02-09
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
radiotherapy, Surgery - Esophageal Cancer, Chemoradiation
Phase 2UnknownShanghai Chest Hospital502016-01-012016-10-19
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
Docetaxel, Fluorouracil - Esophageal Neoplasm, Chemoradiation
Phase 2UnknownZhu Yujia1202010-10-012016-11-21

Narrower conditions

Esophageal Squamous Cell Carcinoma (3)  ·  Esophageal Neoplasms (2)  ·  Stomach Neoplasms (1)

Broader conditions

Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Esophageal Diseases (4)  ·  Head and Neck Neoplasms (4)  ·  Carcinoma (3)  ·  Carcinoma, Squamous Cell (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Squamous Cell (3)  ·  Esophageal Neoplasms (2)  ·  Stomach Diseases (1)

Interventions

Radiotherapy (2)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Docetaxel (1)  ·  Esophagectomy (1)  ·  Fluorouracil (1)  ·  Neoadjuvant Therapy (1)  ·  Paclitaxel (1)  ·  S 1 (combination) (1)  ·  Surgical Procedures, Operative (1)  ·  tislelizumab (1)

Sponsors

Chinese Academy of Medical Sciences (1)  ·  Jiangsu Cancer Institute & Hospital (1)  ·  National Taiwan University Hospital (1)  ·  Shanghai Chest Hospital (1)  ·  Zhu Yujia (1)

Countries

China (4)  ·  Taiwan (1)

Top investigators

Xiangzhi Zhu, Dr. (1)  ·  Xiaolong Fu, Ph.D (1)  ·  Yonghong Hu, MD (1)

Results publications

PMID 30089457, PMID 35219300, PMID 37700348